Blood Res.  2013 Jun;48(2):149-151. 10.5045/br.2013.48.2.149.

Hematological malignancies complicating beta-thalassemia syndromes: a single center experience

• Alavi S
• Safari A
• Sadeghi E
• Amiri S

• KMID: 2172915
• DOI: http://doi.org/10.5045/br.2013.48.2.149

Abstract

No abstract available.

MeSH Terms

beta-Thalassemia
Hematologic Neoplasms

Reference

1. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005; 353:1135–1146. PMID: 16162884.

2. Telfer P. Update on survival in thalassemia major. Hemoglobin. 2009; 33:S76–S80. PMID: 20001636.

3. Chaidos A, Makis A, Hatzimichael E, et al. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. Acta Haematol. 2004; 111:189–195. PMID: 15153710.

4. Alymara V, Bourantas D, Chaidos A, et al. Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiprone. Hematol J. 2004; 5:475–479. PMID: 15570288.

5. Benetatos L, Alymara V, Vassou A, Bourantas KL. Malignancies in beta-thalassemia patients: a single-center experience and a concise review of the literature. Int J Lab Hematol. 2008; 30:167–172. PMID: 18333849.

6. Otrock ZK, Shamseddine AI, Taher AT. Non-Hodgkin disease in beta-thalassemia major. Am J Hematol. 2006; 81:62–64. PMID: 16369971.

7. Sallam MM, Alsuliman AM, Alahmed HE, Alabdulaali MK. Chronic myelogenous leukemia in sickle cell/beta 0-thalassemia. Indian J Pathol Microbiol. 2011; 54:597–598. PMID: 21934232.

8. Thapa R, Pal PK, Mukhopadhyay M. Beta thalassemia major and hodgkin lymphoma. J Pediatr Hematol Oncol. 2009; 31:462–463. PMID: 19648798.

9. Tozzi-Cecchetti MC, D'Amelio R, Baroni CD. Thalassemia major terminating in a non-Hodgkin B-cell lymphoma: report of a case. Tumori. 1979; 65:353–357. PMID: 380092.

10. Schilirò G, Russo A, Marino S, Musumeci S, Russo G. Occurrence of lymphoma with bone marrow involvement in a boy with beta+ thalassaemia major. Clin Lab Haematol. 1979; 1:325–328. PMID: 544148.

11. Chehal A, Loutfi R, Taher A. Beta-thalassemia intermedia and non-Hodgkin's lymphoma. Hemoglobin. 2002; 26:219–225. PMID: 12403486.

12. Quattrin N, Mastrobouni A, Laudisio FL, Brancaccio V, Pagnini D. Hb Lepore and (haemo-) blastomata. Folia Haematol Int Mag Klin Morphol Blutforsch. 1976; 103:915–919. PMID: 64434.

13. Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989; 2:27–30. PMID: 2567801.

14. Al-Jam'a AH, Al-Dabbous IA, Al-Khatti AA, Esan FG. Are we underestimating the leukemogenic risk of hydroxyurea. Saudi Med J. 2002; 23:1411–1413. PMID: 12506308.

15. Stevens RG, Jones DY, Micozzi MS, Taylor PR. Body iron stores and the risk of cancer. N Engl J Med. 1988; 319:1047–1052. PMID: 3173433.